Erlanger Neuroscience Institute

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Myasthenia gravis2 trials
• CIDP (chronic inflammatory demyelinating polyneuropathy)1 trial

Phase

• Phase 42 trials
• Phase 31 trial

Status

• Active, not recruiting1 trial
• Completed1 trial
• Recruiting1 trial

Lead sponsor

• argenx3 trials

Running trials

• Recruiting

  A Study to Evaluate the Clinical Outcomes of Efgartigimod PH20 SC in Adults With New-onset Generalized Myasthenia Gravis (gMG)

  NCT06909214· Phase 4· argenx· Source

  Contact: Joshua Alpers, MD

• Active, not recruiting

  A Phase 3 Study to Evaluate the Efficacy and Safety of Efgartigimod IV in Patients With Acetylcholine Receptor Binding Antibody Seronegative Generalized Myasthenia Gravis

  NCT06298552· Phase 3· argenx· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Myasthenia gravis1 recruiting

Closed trials

• Completed

  A Study to Assess Adults With CIDP Transitioning From IVIg to Efgartigimod PH20 SC

  NCT06637072· Phase 4· argenx· Source